https://scholars.lib.ntu.edu.tw/handle/123456789/517542
Title: | Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial | Authors: | Reich K. Gooderham M. Tha?i D. Crowley J.J. Ryan C. Krueger J.G. TSEN-FANG TSAI Flack M. Gu Y. Williams D.A. Thompson E.H.Z. Paul C. |
Issue Date: | 2019 | Publisher: | Lancet Publishing Group | Journal Volume: | 394 | Journal Issue: | 10198 | Start page/Pages: | 576-586 | Source: | The Lancet | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070540421&doi=10.1016%2fS0140-6736%2819%2930952-3&partnerID=40&md5=19d657d0f80700630efe09b71f3a2b61 https://scholars.lib.ntu.edu.tw/handle/123456789/517542 |
ISSN: | 0140-6736 | DOI: | 10.1016/S0140-6736(19)30952-3 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.